Severe dilated cardiomyopathy as a consequence of Ecstasy intake

Cardiovascular Pathology

Volumn 17, Issue 4, 2008, Pages 250-253

  Mizia Stec, Katarzyna ^a   Gasior, Zbigniew ^a   Wojnicz, Romuald ^a   Haberka, Maciej ^a   Mielczarek, Marcin ^a   Wierzbicki, Andrzej ^a   Pstraś, Katarzyna ^a   Hartleb, Marek ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Dilated cardiomyopathy; Ecstasy

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; NARCOTIC AGENT; PSYCHEDELIC AGENT;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; CONGESTIVE CARDIOMYOPATHY; DISEASE SEVERITY; GENE MUTATION; HEART FAILURE; HUMAN; LIVER INJURY; LIVER TOXICITY; MALE; METABOLIC DISORDER; NEUROMUSCULAR DISEASE; NUTRITIONAL DISORDER; PHEOCHROMOCYTOMA; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SYSTEMIC DISEASE; VIRUS INFECTION;

ADULT; CARDIOMYOPATHY, DILATED; HALLUCINOGENS; HEART; HEART FAILURE; HLA ANTIGENS; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; LIVER; MALE; MYOCARDIUM; MYOCYTES, CARDIAC; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; SUBSTANCE-RELATED DISORDERS;

EID: 47149102753     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carpath.2007.07.006     Document Type: Article

References (12)

1. Maron B., Towbin J., Thiene G., Antzelevitch C., Corrado D., Arnett D., et al. Contemporary definitions and classification of the cardiomyopathies. Circulation 113 (2006) 1807-1816
2. Wijetunga M., Seto T., Lindsay J., and Schatz I. Crystal methamphetamine-associated cardiomyopathy: tip of the iceberg?. J Toxicol Clin Toxicol 41 (2003) 981-986
3. Mortelmans L., Bogaerts P., Hellemans S., Volders W., and Van-Rossom P. Spontaneous pneumomediastinum and myocarditis following Ecstasy use: a case report. Eur J Emerg Med 12 (2005) 116-118
4. Yeo K., Wijetunga M., Ito H., Efird I., Tay K., Seto T., et al. The association of methamphetamine use and cardiomyopathy in young patients. Am J Med 120 (2007) 165-171
5. Parikh P., Nicolaidis L., Stolarski C., Shen Y., and Shannon R. Chronic exposure to cocaine binging predisposes to an accelerated course of dilated cardiomyopathy in conscious dogs following rapid ventricular pacing. J Pharmacol Exp Ther 315 (2005) 1013-1019
6. Mathier M., Shen Y., and Shannon R. Exaggerated cardiovascular effects of cocaine in conscious dogs with pacing-induced dilated cardiomyopathy. J Card Fail 8 (2002) 407-415
7. Chen J., Ke Q., Xiao Y., Wu G., Kaplan E., Hampton T., et al. Cocaine and catecholamines enhance inflammatory cell retention in the coronary circulation of mice by upregulation of adhesion molecules. Am J Physiol Heart Circ Physiol 288 (2005) H2323-H2331
8. Pitts W., Vongpatanasin W., Cigarroa J., Hillis D., and Lange R. Effects of the intracoronary infusion of cocaine on left ventricular systolic and diastolic function in humans. Circulation 97 (1998) 1270-1273
9. Karch S., Stephens B., and Ho C. Methamphetamine-related deaths in San Francisco: demographic, pathologic, and toxicologic profiles. J Forensic Sci 44 (1999) 359-368
10. Wojnicz R., Nowak J., Szygula-Jurkiewicz B., Wilczek K., Lekston A., Trzeciak P., et al. Adjunctive therapy with low-molecular-weight heparin in patients with chronic heart failure secondary to dilated cardiomyopathy: one-year follow-up results of the randomized trial. Am Heart J 152 (2006) 713.e1-713.e7
11. Kaye S., and McKetin R. Cardiotoxicity associated with methamphetamine use and signs of cardiovascular pathology among methamphetamine users. NDARC Technical Report No. 238. NDARC (2005)
12. Jones A., and Simpson K. Review article: mechanisms and management of hepatotoxicity in ecstasy (MDMA) and amphetamine intoxications. Aliment Pharmacol Ther 13 (1999) 129-133